In this study, we preliminarily verified the relationship between CAMK2B and the malignant progression of glioma, and demonstrated through a series of experiments that this relationship is established via the Ras/Raf/MEK/ERK signaling pathway. This evidence concerns the gene CAMK2B and central nervous system cancer.